Information about ExpressMedsCanada.com
List of countries where we can ship Spectracef:
Latest news releases on Spectracef:
The decrease was primarily due to the Company's divestiture of its Factive and Spectracef product rights and respiratory sales force. Research and development expenses increased $486,000, or 87%, during the first quarter of 2012 compared to the ...
In March, the company divested itself of two antibiotics, Factive and Spectracef, that were sold to doctors' offices. In a statement, Cornerstone CEO Craig Collard said the EKR acquisition is a major step forward in its strategy of targeting the hospital market.